AU2002216033A1 - Use of pyrazolo(4,3-d)pyrimidines - Google Patents

Use of pyrazolo(4,3-d)pyrimidines

Info

Publication number: AU2002216033A1
Authority: AU; Australia
Prior art keywords: pyrazolo; pyrimidines
Prior art date: 2000-12-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002216033A

Inventor

Hans-Michael Eggenweiler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-05

Filing date

2001-11-09

Publication date

2002-06-18

2001-11-09 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

2002-06-18 Publication of AU2002216033A1 publication Critical patent/AU2002216033A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

AU2002216033A 2000-12-05 2001-11-09 Use of pyrazolo(4,3-d)pyrimidines Abandoned AU2002216033A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10060388A DE10060388A1 (en)	2000-12-05	2000-12-05	Use of pyrazolo [4,3-d] pyrimidines
DE10060388		2000-12-05
PCT/EP2001/013036 WO2002045716A1 (en)	2000-12-05	2001-11-09	Use of pyrazolo[4,3-d]pyrimidines

Publications (1)

Publication Number	Publication Date
AU2002216033A1 true AU2002216033A1 (en)	2002-06-18

Family

ID=7665844

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002216033A Abandoned AU2002216033A1 (en)	2000-12-05	2001-11-09	Use of pyrazolo(4,3-d)pyrimidines

Country Status (17)

Country	Link
US (1)	US20040023991A1 (en)
EP (1)	EP1339410A1 (en)
JP (1)	JP2004523493A (en)
KR (1)	KR20030055338A (en)
CN (1)	CN1479619A (en)
AU (1)	AU2002216033A1 (en)
BR (1)	BR0115911A (en)
CA (1)	CA2436916A1 (en)
CZ (1)	CZ20031752A3 (en)
DE (1)	DE10060388A1 (en)
HU (1)	HUP0302645A3 (en)
MX (1)	MXPA03004907A (en)
PL (1)	PL361890A1 (en)
RU (1)	RU2003119546A (en)
SK (1)	SK8072003A3 (en)
WO (1)	WO2002045716A1 (en)
ZA (1)	ZA200305181B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19942474A1 (en) *	1999-09-06	2001-03-15	Merck Patent Gmbh	Pyrazolo [4,3-d] pyrimidines
ATE478872T1 (en) *	2002-03-28	2010-09-15	Ustav Ex Botan Av Cr V V I I O	PYRAZOLOA4,3-DÜPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC USE
KR100468352B1 (en) *	2002-09-24	2005-01-27	한국과학기술연구원	New pyrazolopyrimidine derivatives, process for their preparation and pharmaceutical composition comprising the same
ATE475421T1 (en) *	2003-05-06	2010-08-15	Ustav Ex Botan Akademie Ved Ce	PYRAZOLOA4,3-DÜPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
BRPI0906475A2 (en)	2008-01-11	2015-07-14	Natco Pharma Ltd	Compounds, process for preparing a compound, pharmaceutical composition and use of a compound
TW202019425A (en) *	2018-07-20	2020-06-01	德商馬克專利公司	Methods for treatment and prevention of multiple sclerosis using substituted amino-pyrimidine compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1530747A (en) *	1976-04-05	1978-11-01	Massachusetts Inst Technology	Pharmaceutical composition
CA2238283C (en) *	1997-05-30	2002-08-20	Cell Pathways, Inc.	Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US5858694A (en) *	1997-05-30	1999-01-12	Cell Pathways, Inc.	Method for identifying compounds for inhibition of cancerous lesions

2000
- 2000-12-05 DE DE10060388A patent/DE10060388A1/en not_active Withdrawn
2001
- 2001-11-09 RU RU2003119546/15A patent/RU2003119546A/en not_active Application Discontinuation
- 2001-11-09 KR KR10-2003-7007498A patent/KR20030055338A/en not_active Application Discontinuation
- 2001-11-09 HU HU0302645A patent/HUP0302645A3/en unknown
- 2001-11-09 WO PCT/EP2001/013036 patent/WO2002045716A1/en not_active Application Discontinuation
- 2001-11-09 CA CA002436916A patent/CA2436916A1/en not_active Abandoned
- 2001-11-09 SK SK807-2003A patent/SK8072003A3/en unknown
- 2001-11-09 CZ CZ20031752A patent/CZ20031752A3/en unknown
- 2001-11-09 BR BR0115911-9A patent/BR0115911A/en not_active Application Discontinuation
- 2001-11-09 US US10/433,678 patent/US20040023991A1/en not_active Abandoned
- 2001-11-09 MX MXPA03004907A patent/MXPA03004907A/en unknown
- 2001-11-09 JP JP2002547500A patent/JP2004523493A/en active Pending
- 2001-11-09 AU AU2002216033A patent/AU2002216033A1/en not_active Abandoned
- 2001-11-09 PL PL01361890A patent/PL361890A1/en unknown
- 2001-11-09 EP EP01999373A patent/EP1339410A1/en not_active Withdrawn
- 2001-11-09 CN CNA018200737A patent/CN1479619A/en active Pending
2003
- 2003-07-03 ZA ZA200305181A patent/ZA200305181B/en unknown

Also Published As

Publication number	Publication date
CA2436916A1 (en)	2002-06-13
CN1479619A (en)	2004-03-03
RU2003119546A (en)	2004-12-27
MXPA03004907A (en)	2003-09-05
HUP0302645A3 (en)	2005-05-30
SK8072003A3 (en)	2003-10-07
PL361890A1 (en)	2004-10-04
KR20030055338A (en)	2003-07-02
HUP0302645A2 (en)	2003-11-28
BR0115911A (en)	2004-02-25
EP1339410A1 (en)	2003-09-03
US20040023991A1 (en)	2004-02-05
ZA200305181B (en)	2004-10-04
CZ20031752A3 (en)	2003-10-15
WO2002045716A1 (en)	2002-06-13
JP2004523493A (en)	2004-08-05
DE10060388A1 (en)	2002-06-06

Publication	Publication Date	Title
SI1220856T1 (en)	2005-06-30	Pyrazolo(4,3-d)pyrimidine derivatives
EP1416935B8 (en)	2008-08-27	4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
IL158697A0 (en)	2004-05-12	4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL152771A0 (en)	2003-06-24	PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
NO20022738D0 (en)	2002-06-07	Pyrrolo (2,3-d) pyrimidine
AU2002327168A1 (en)	2002-12-23	Pyrrolo(2,3-d)pyrimidine nucleoside analogs
SI1087971T1 (en)	2004-10-31	PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
PL353366A1 (en)	2003-11-17	Pyrazolo[4,3-d]pyrimidines
AU5491699A (en)	2000-03-14	Process for the preparation of pyrrolo(2,3-d)pyrimidines
AU2001279700A1 (en)	2002-03-28	5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
PL358551A1 (en)	2004-08-09	5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
AU2002215979A1 (en)	2002-06-03	Use of pyrazolo(4,3-D)pyrimidines
AU2002216033A1 (en)	2002-06-18	Use of pyrazolo(4,3-d)pyrimidines
AU2001285785A1 (en)	2002-03-28	2-aminoalkyl-thieno[2,3-d]pyrimidines
AU2001233026A1 (en)	2001-08-07	Phosphodiesterases
AU8578501A (en)	2002-01-08	2-aminoalkyl-thieno(2,3-d)pyrimidines
AU2002210526A1 (en)	2002-06-27	Substituted 3.4-dihydro-pyrido[1,2-A]pyrimidines
IL155380A0 (en)	2003-11-23	SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
AU2001281142A1 (en)	2002-02-25	Diazepinones as antiviral agents
AU2002214007A1 (en)	2002-04-22	Substituted 3.4-dihydro-pyrimido(1,2-A)pyrimidines and 3.4-dihydropyrazino(1,2-A)pyrimidines
SI1210349T1 (en)	2003-06-30	PYRAZOLO 4,3-d)PYRIMIDINES
AU2002325550A1 (en)	2003-03-18	(1,2,4)triazolo(1,5-a)pyrimidine derivative
AU2002226519A1 (en)	2002-07-24	Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists
AU2002244935A1 (en)	2002-10-15	8-thiazolyl(1,2,4)triazolo(1,5-c)pyrimidine derivative
AU2001291210A1 (en)	2002-07-08	Process for the preparation of 2-alkoxy-6-trifluoromethyl-n-((1,2,4)triazolo(1,5-c)pyrimidin-2-yl)benzenesulfonamides